Population-Based Study of Time to Insulin After Failure of Oral Antidiabetic (OA) Therapy in Type 2 Diabetes (T2DM) in the UK

Jun-06

AUTHORS : Dr Annalisa Rubino (Details for study: RTI Health Solutions), Astrazeneca, Cambridge, United Kingdom – Email: annalisa.rubino@astrazeneca.com

JOURNAL : Diabetes

REFERENCE: 55(S1):A76 (Abstract324-OR)

DOI :

Population-Based Study of Time to Insulin After Failure of Oral Antidiabetic (OA) Therapy in Type 2 Diabetes (T2DM) in the UK

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease